logo iconlogo
language icon
language icon
banner

About

DAMO MED leverages AI to enable multi-disease screening through a single non-contrast CT scan, advancing accessible healthcare for all.

Contact Us
arrow
Introduction
DAMO Academy Medical AI Team
AI-Powered Healthcare Innovation

DAMO Academy Medical AI Team

The DAMO Academy Medical AI Team focuses on medical imaging AI. Specializing in high-incidence cancers (e.g., pancreatic, esophageal), their breakthroughs have been published in Nature Medicine, Nature Communications, and top AI conferences (e.g., CVPR, MICCAI, IPMI).

DAMO MED
Multi-disease screen via non-contrast CT

DAMO MED

DAMO MED, developed by DAMO Academy, enables simultaneous detection of pancreatic cancer, acute aortic syndrome, esophageal cancer, and other diseases through a single non-contrast CT scan. This solution provides full process technical support across the entire workflow for clinical doctors in over 1500 medical institutions, achieving "One-Scan, Multi-Screening" healthcare access.

Our Development Journey

2024

DAMO MED Technology Advancement and Implementation

Sole Chinese representative listed alongside GPT-4, Gemini and Claude 3 in Stanford's 2024 AI Index Report as global highlighted research

WHO Digital Health Collaboration Center promotes DAMO's cancer screening technology worldwide

Selected in the 2024 World Internet Conference Leading Technology Award Compendium

DAMO MED has integrated with 30+ leading medical imaging ISVs, providing technical support to over 1500 medical institutions

2023

Major Breakthrough in Pancreatic Cancer Screening

DAMO PANDA for pancreatic cancer screening published in Nature Medicine

"Hierarchical Segmentation Model for Human Organs" selected as 2023 representative AI algorithm in Chinese medical AI

2022

DAMO MED Launches "One-Scan, Multi-Screening" Technology

Released "One-Scan, Multi-Screening" solution based on Non-Contrast CT

Research papers on esophageal cancer screening and colorectal cancer screening were published at MICCAI 2022

2021

Development of Multi-Disease Screening Technology

Initiated "One-Scan, Multi-Screening" strategic project, validating feasibility of "Non-Contrast CT+AI" technology

2020

Technological Breakthroughs in Major Public Health Events

Released CT-based COVID-19 diagnostic technology

Received national commendation as outstanding collective and individual in COVID-19 fight

2019

Construction of Chronic Disease Assessment System

Launched whole-body multi-site fracture and osteoporosis detection capabilities

Jointly released KL grading application with domestic orthopedic platform

2018

Early Exploration of Tumor Screening Technology

Pulmonary nodule technology released, landing in Meinian Health

2017

Establishment of Medical AI Team

DAMO Academy formed medical AI research team

Won championship at LUNA16, the authoritative international lung nodule detection competition

Our Achievements
Contact Us
DAMOMED@alibaba-inc.com
19558206560
Policies
Legal Notice
Wechat
Copyright © Alibaba Damo Academy (Beijing) Technology Co., Ltd.
DAMOMED@alibaba-inc.com
19558206560
Contact Us